Compare stocks

AddLife AB is a company active in the life sciences sector, providing products, services, and solutions primarily to healthcare and research facilities. Its operations are divided into two major segments: Labtech, which offers laboratory equipment, diagnostics, and consumables, and Medtech, which supplies medical devices and healthcare solutions. Founded in Sweden in 2015, AddLife operates across Europe with its headquarters in Stockholm. The company's strategic focus lies in leveraging its extensive network and expertise to cater to the specialized needs of its customers, supporting advances in life sciences and medical technology.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.